首页 > 文章详情

【“御黑·论道”第五期】Caroline Robert教授解读2020 ASCO恶性黑色素瘤治疗新进展

2020年06月23日

整理：肿瘤资讯

来源：肿瘤资讯

在近几年的ASCO大会上，黑色素瘤的治疗一直在创造一个又一个神话。2020年ASCO于5月29日以线上会议的形式正式拉开帷幕，黑色素瘤领域研究新进展、新药物百花齐放。其中，双靶辅助治疗研究COMBI-AD五年生存分析数据重磅公布，再次证实D+T双靶治疗可以带来长期的生存获益。此外，针对免疫＋靶向治疗全新模式的探索也成为与会专家学者关注的热点。

由【肿瘤资讯】和诺华肿瘤医学部共同策划的“御黑·论道”公开课即将于6月23日（周二）12:00-12:30隆重上线，与各位临床医生见面。第五期，我们非常荣幸地邀请到了法国Gustave Roussy癌症研究所的Caroline Robert教授与我们进行专题分享。

Caroline Robert

M.D., Ph.D

Caroline Robert, M.D., Ph.D., is the Head of the Dermatology Unit at Gustave Roussy and co-director of the Melanoma Research Unit at INSERM 981 Paris-Sud University.
She chaired the Melanoma group of the European Organization for the Research and Treatment of Cancer (EORTC) from 2014 to 2017 and she is board member for the European Association of Onco-Dermatology (EADO), the European Society of Medical Oncology (ESMO), the European Association of Dermato-Venereology (EADV) the French society of Dermatology and Venereology (SFD), the American Society of Oncology (ASCO) and the American Association of Clinical Research (AACR).
Her main focuses of interest are clinical and translational research on Melanoma, immunotherapy and targeted therapy, as well as the study of the cutaneous adverse events of anticancer agents. Caroline Robert is national and international coordinator of many clinical trials of targeted therapy and immunotherapy for melanoma patients, from phase I to III. She has authored more than 325 articles in peer-reviewed scientific journals, including a number of publications on new treatments for metastatic melanoma
Her recent work has focused on identification of new biomarkers for immunotherapy and targeted therapies of patients with melanoma

ASCO 2020精粹——黑色素瘤领域学术亮点

讲者：Caroline Robert教授

黑色素瘤死亡率高、预后差，近年来随着靶向治疗、免疫治疗的发展，黑色素瘤成为研究热点，治疗也进入了崭新的阶段。2020 ASCO这场学术盛会展示了黑色素瘤领域最前沿的研究，覆盖了晚期治疗、辅助治疗、新辅助治疗等多个方面。免疫治疗耐药的患者其后续治疗有哪些最新循证医学证据？靶向＋免疫的全新治疗模式客观缓解率如何？对于BRAF V600突变的Ⅲ期黑色素瘤患者，随访时间最长的双靶联合辅助治疗研究COMBI-AD将给我们带来哪些启示？黑色素瘤新辅助治疗又有哪些最新探索？

法国Gustave Roussy癌症研究所的Caroline Robert教授将对本次ASCO大会的重磅研究进行解析，精彩不容错过！